TALEA GROUP S.P.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.56 EUR | 0.00% |
|
-8.85% | -36.38% |
| May. 07 | Talea Group launches its private label branded Farmaè | AN |
| Apr. 23 | Talea closes first quarter with revenues up | AN |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 221.1 | 75.31 | 38.02 | - | - |
| Enterprise Value (EV) 1 | 221.1 | 96.61 | 72.17 | 70.32 | 65.97 |
| P/E ratio | - | - | -33.8 x | 11.8 x | 6.49 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 2.68 x | 0.65 x | 0.22 x | 0.18 x | 0.16 x |
| EV / Revenue | 2.68 x | 0.83 x | 0.43 x | 0.34 x | 0.28 x |
| EV / EBITDA | - | 38.6 x | 19 x | 7.52 x | 5 x |
| EV / FCF | - | - | 9.25 x | 52.1 x | 17.1 x |
| FCF Yield | - | - | 10.8% | 1.92% | 5.84% |
| Price to Book | - | - | 1.28 x | 1.16 x | 0.98 x |
| Nbr of stocks (in thousands) | 6,846 | 6,846 | 6,838 | - | - |
| Reference price 2 | 32.30 | 11.00 | 5.560 | 5.560 | 5.560 |
| Announcement Date | 4/14/22 | 3/28/23 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | 82.48 | 116.3 | 169.2 | 206.4 | 232.8 |
| EBITDA 1 | - | 2.5 | 3.8 | 9.35 | 13.2 |
| EBIT 1 | - | -0.0382 | 0.4 | 5.6 | 9.25 |
| Operating Margin | - | -0.03% | 0.24% | 2.71% | 3.97% |
| Earnings before Tax (EBT) 1 | - | -0.8418 | -0.95 | 4.5 | 8.25 |
| Net income 1 | -0.0897 | -0.9076 | -1.15 | 3.25 | 5.85 |
| Net margin | -0.11% | -0.78% | -0.68% | 1.57% | 2.51% |
| EPS 2 | - | - | -0.1645 | 0.4705 | 0.8570 |
| Free Cash Flow 1 | - | - | 7.8 | 1.35 | 3.85 |
| FCF margin | - | - | 4.61% | 0.65% | 1.65% |
| FCF Conversion (EBITDA) | - | - | 205.26% | 14.44% | 29.17% |
| FCF Conversion (Net income) | - | - | - | 41.54% | 65.81% |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 4/14/22 | 3/28/23 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 S1 |
|---|---|
| Net sales 1 | 72.93 |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income | - |
| Net margin | - |
| EPS | - |
| Dividend per Share | - |
| Announcement Date | 9/26/23 |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | 21.3 | 34.2 | 32.3 | 28 |
| Net Cash position 1 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 8.52 x | 8.987 x | 3.455 x | 2.117 x |
| Free Cash Flow 1 | - | - | 7.8 | 1.35 | 3.85 |
| ROE (net income / shareholders' equity) | - | - | -3.75% | 9.95% | 15.7% |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share 2 | - | - | 4.340 | 4.810 | 5.660 |
| Cash Flow per Share | - | - | - | - | - |
| Capex 1 | - | - | 5.1 | 5.75 | 6 |
| Capex / Sales | - | - | 3.02% | 2.79% | 2.58% |
| Announcement Date | 4/14/22 | 3/28/23 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.56
EUR
Average target price
11.25
EUR
Spread / Average Target
+102.34%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -36.38% | 39.77M | |
| +9.15% | 195B | |
| -3.96% | 189B | |
| +49.33% | 94.05B | |
| +6.73% | 85.88B | |
| -24.54% | 75.95B | |
| +11.41% | 52.63B | |
| +19.19% | 25.83B | |
| +29.11% | 11.11B | |
| -5.35% | 8.62B |
- Stock Market
- Equities
- FAR Stock
- Financials Talea Group S.p.A.